63 related articles for article (PubMed ID: 20196871)
1. Influence of PARP-1 polymorphisms in patients after traumatic brain injury.
Sarnaik AA; Conley YP; Okonkwo DO; Barr TL; Fink EL; Szabo C; Kochanek PM; Clark RS
J Neurotrauma; 2010 Mar; 27(3):465-71. PubMed ID: 19925161
[TBL] [Abstract][Full Text] [Related]
2. Role of one-carbon metabolizing pathway genes and gene-nutrient interaction in the risk of non-Hodgkin lymphoma.
Li Q; Lan Q; Zhang Y; Bassig BA; Holford TR; Leaderer B; Boyle P; Zhu Y; Qin Q; Chanock S; Rothman N; Zheng T
Cancer Causes Control; 2013 Oct; 24(10):1875-84. PubMed ID: 23913011
[TBL] [Abstract][Full Text] [Related]
3. A pooled analysis of three studies evaluating genetic variation in innate immunity genes and non-Hodgkin lymphoma risk.
Hosgood HD; Purdue MP; Wang SS; Zheng T; Morton LM; Lan Q; Menashe I; Zhang Y; Cerhan JR; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Schenk M; Zahm SH; Chatterjee N; Chanock SJ; Rothman N; Hartge P; Armstrong B
Br J Haematol; 2011 Mar; 152(6):721-6. PubMed ID: 21250972
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.
Lan Q; Morton LM; Armstrong B; Hartge P; Menashe I; Zheng T; Purdue MP; Cerhan JR; Zhang Y; Grulich A; Cozen W; Yeager M; Holford TR; Vajdic CM; Davis S; Leaderer B; Kricker A; Schenk M; Zahm SH; Chatterjee N; Chanock SJ; Rothman N; Wang SS
Blood; 2009 Jul; 114(2):264-7. PubMed ID: 19414860
[TBL] [Abstract][Full Text] [Related]
5. Association of LIN28B Gene Polymorphisms (rs221634, rs221635, rs314276, rs9404590, and rs12194974) with Non-Hodgkin Lymphoma Susceptibility and Clinical/Pathological Features.
Aghighi A; Nakhaee A; Taheri M; Hashemi SM; Bahari G
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3867-3874. PubMed ID: 38019245
[TBL] [Abstract][Full Text] [Related]
6.
Xin Y; Yang L; Su M; Cheng X; Zhu L; Liu J
J Int Med Res; 2021 Mar; 49(3):300060521992956. PubMed ID: 33706586
[TBL] [Abstract][Full Text] [Related]
7. Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
Bashir K; Sarwar R; Saeed S; Mahjabeen I; Kayani MA
PLoS One; 2018; 13(9):e0199007. PubMed ID: 30183716
[TBL] [Abstract][Full Text] [Related]
8. PARP-1 Val762Ala polymorphism and risk of cancer: a meta-analysis based on 39 case-control studies.
Qin Q; Lu J; Zhu H; Xu L; Cheng H; Zhan L; Yang X; Zhang C; Sun X
PLoS One; 2014; 9(5):e98022. PubMed ID: 24853559
[TBL] [Abstract][Full Text] [Related]
9. Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies.
Hua RX; Li HP; Liang YB; Zhu JH; Zhang B; Ye S; Dai QS; Xiong SQ; Gu Y; Sun XZ
PLoS One; 2014; 9(1):e87057. PubMed ID: 24489833
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.
Curtin NJ; Szabo C
Mol Aspects Med; 2013 Dec; 34(6):1217-56. PubMed ID: 23370117
[TBL] [Abstract][Full Text] [Related]
11. The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.
Quốc Lu'o'ng KV; Nguyễn LT
Cancer Manag Res; 2012; 4():431-45. PubMed ID: 23293538
[TBL] [Abstract][Full Text] [Related]
12. Lack of an association between two BER gene polymorphisms and breast cancer risk: a meta-analysis.
Wu B; Liu HL; Zhang S; Dong XR; Wu G
PLoS One; 2012; 7(12):e50857. PubMed ID: 23272074
[TBL] [Abstract][Full Text] [Related]
13. Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.
Pabalan N; Francisco-Pabalan O; Jarjanazi H; Li H; Sung L; Ozcelik H
Mol Biol Rep; 2012 Dec; 39(12):11061-72. PubMed ID: 23073772
[TBL] [Abstract][Full Text] [Related]
14. Correlation between base-excision repair gene polymorphisms and levels of in-vitro BPDE-induced DNA adducts in cultured peripheral blood lymphocytes.
Yu H; Zhao H; Wang LE; Liu Z; Li D; Wei Q
PLoS One; 2012; 7(7):e40131. PubMed ID: 22792228
[TBL] [Abstract][Full Text] [Related]
15. Association between PARP-1 V762A polymorphism and cancer susceptibility: a meta-analysis.
Yu H; Ma H; Yin M; Wei Q
Genet Epidemiol; 2012 Jan; 36(1):56-65. PubMed ID: 22127734
[TBL] [Abstract][Full Text] [Related]
16. PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males.
Jin XM; Kim HN; Lee IK; Park KS; Kim HJ; Choi JS; Juhng SW; Choi C
BMC Med Genet; 2010 Mar; 11():38. PubMed ID: 20196871
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between poly(ADP-ribose) polymerase (PARP) polymorphisms and rheumatoid arthritis in a Korean population.
Lee KA; Bang SY; Park BL; Kim JH; Shin HD; Bae SC
Rheumatol Int; 2012 Jan; 32(1):91-6. PubMed ID: 20665026
[TBL] [Abstract][Full Text] [Related]
18. Involvement of PARP-1 Val762Ala polymorphism in the onset of cervical cancer in caucasian women.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2013 Aug; 17(4):239-45. PubMed ID: 23633189
[TBL] [Abstract][Full Text] [Related]
19. PARP-1 Val762Ala polymorphism is associated with risk of cervical carcinoma.
Ye F; Cheng Q; Hu Y; Zhang J; Chen H
PLoS One; 2012; 7(5):e37446. PubMed ID: 22624032
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
